| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1035441B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0135441 |
| P932 | PMC publication ID | 4540473 |
| P698 | PubMed publication ID | 26285213 |
| P5875 | ResearchGate publication ID | 281722522 |
| P50 | author | Maria Pia Amato | Q56451881 |
| Diego Centonze | Q42218235 | ||
| P2093 | author name string | Ruggero Capra | |
| Alessandra Sottini | |||
| Diego Bertoli | |||
| Federico Serana | |||
| Luisa Imberti | |||
| Davide Maimone | |||
| Cinzia Cordioli | |||
| Ciro Florio | |||
| Elisa Puma | |||
| P2860 | cites work | Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma. | Q53082272 |
| Neutralization of pyrogen-induced tumour necrosis factor by its type 1 soluble receptor in guinea-pigs: effects on fever and interleukin-6 release. | Q53353859 | ||
| C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. | Q53850007 | ||
| Cytokine gene polymorphisms in Taiwan. | Q53885766 | ||
| Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis | Q57487166 | ||
| Amelioration of flulike symptoms at the onset of interferon β- 1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction | Q57602164 | ||
| Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis | Q57912405 | ||
| Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis | Q73086562 | ||
| Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group | Q77573170 | ||
| Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection | Q79426165 | ||
| Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay | Q82225806 | ||
| Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular interferon beta-1a therapy: a pilot study | Q94534821 | ||
| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
| Interferon-β-1b: a review of its use in multiple sclerosis | Q28299838 | ||
| Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans | Q30578885 | ||
| Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin | Q33393620 | ||
| MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients | Q35148010 | ||
| Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. | Q35206277 | ||
| US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profiles | Q36058902 | ||
| Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
| Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients | Q36091339 | ||
| The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis | Q37385249 | ||
| Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial. | Q40528206 | ||
| Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy | Q40585200 | ||
| Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta? | Q40620663 | ||
| Lack of cross tolerance between LPS and muramyl dipeptide in induction of circulating TNF-alpha and IL-6 in guinea pigs | Q40645006 | ||
| Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice | Q40655674 | ||
| Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery | Q40686433 | ||
| Systemic but not central administration of tumor necrosis factor-alpha attenuates LPS-induced fever in rats | Q40688766 | ||
| Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms | Q40706826 | ||
| Systemic injection of TNF-alpha attenuates fever due to IL-1 beta and LPS in rats | Q40727253 | ||
| Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats | Q40757988 | ||
| Side effect profile of interferon beta-1b in MS: results of an open label trial | Q40952067 | ||
| A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro | Q43458583 | ||
| Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis | Q43876866 | ||
| Differential modulation of interleukin-6 and interleukin-10 by diclofenac in patients undergoing major surgery | Q44098460 | ||
| Time of interferon-beta 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients | Q46925584 | ||
| An investigation of polymorphism in the interleukin-10 gene promoter | Q48054541 | ||
| Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis | Q48319807 | ||
| Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? | Q50096890 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0135441 | |
| P577 | publication date | 2015-08-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene | |
| P478 | volume | 10 |
| Q33883508 | Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study | cites work | P2860 |
Search more.